Daily Archives: September 25, 2016

Prospect of Shorter Treatment and Cure for Chronic Myelogenous Leukemia

dana-farber-release_leukemia_hypolobated_small_megakaryocyte

Although targeted drugs like Gleevec have revolutionized the treatment of chronic myelogenous leukemia (CML), patients generally must take them for the rest of their lives and may cease benefiting from them over time. In new research that could suggest a road to a cure, scientists at Harvard-affiliated Dana-Farber Cancer Institute …

Read More »